Mice with intestinal epithelium-specific deletion of Klf4 (Klf4ΔIS) treated with AOM and DSS developed significantly more adenomatous polyps and carcinomas in situ in comparison to treated control Klf4fl/fl mice. Here, KLF4 is linked to cancer.